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Abstract
Background: Although nicotine alters serotonergic neurochemistry, clinical trials of serotonergic medications for smoking 
cessation have provided mixed results. Understanding the role of serotonergic dysfunction in tobacco use disorder may 
advance development of novel pharmacotherapies.
Methods: Functional magnetic resonance imaging was used to measure resting-state functional connectivity of the raphe 
nuclei as an indicator of serotonergic function. Connectivity of the dorsal and median raphe nuclei was compared between 
18 young smokers (briefly abstinent, ~40 minutes post-smoking) and 19 young nonsmokers (16–21 years old); connectivity 
was also examined in a separate sample of overnight-abstinent smokers (18–25 years old), before and after smoking the first 
cigarette of the day. Relationships between connectivity of the raphe nuclei with psychological withdrawal and craving were 
tested in smokers.
Results: Connectivity of the median raphe nucleus with the right hippocampal complex was weaker in smokers than in 
nonsmokers and was negatively correlated with psychological withdrawal in smokers. In overnight-abstinent smokers, 
smoking increased connectivity of the median raphe nucleus with the right hippocampal complex, and the increase was 
positively correlated with the decrease in psychological withdrawal.
Conclusions: Relief of withdrawal due to smoking is potentially linked to the serotonergic pathway that includes the median 
raphe nucleus and hippocampal complex. These results suggest that serotonergic medications may be especially beneficial 
for smokers who endorse strong psychological withdrawal during abstinence from smoking.
Keywords: smoking, serotonin, craving, psychological withdrawal, fMRI
Introduction
Nicotine, the primary addictive constituent of tobacco smoke, 
affects the serotonergic system. In rodents, injections of nicotine 
into the dorsal raphe nucleus, hippocampus, and prefrontal cor-
tex promote serotonin release in these regions (Ribeiro et al., 1993; 
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Kenny et  al., 2000; Cheeta et  al., 2001), but chronic nicotine 
administration decreases serotonin concentrations in the hip-
pocampus (Benwell and Balfour, 1979). Compared to nonsmok-
ers, smokers have lower levels of serotonin and its metabolite 
5-hydroxyindoleocetic acid (5-HIAA) in the raphe nuclei and hip-
pocampal complex at postmortem assessment (Benwell et al., 
1990), possibly in part because smokers have higher densities 
of 5-HT1A autoreceptors in the median raphe nucleus (Benwell 
et al., 1990). Activation of these receptors inhibits the firing of 
serotonergic neurons in the raphe nuclei, inhibiting serotonin 
release in the cerebral cortex (Blier and Ward, 2003).
The raphe nuclei provide serotonergic innervation through-
out the brain, including the hippocampal complex (Moore and 
Halaris, 1975; Bobillier et al., 1979; 1979). The hippocampal com-
plex has the highest 5-HT1A receptor availability in the brain, as 
indicated by positron emission tomography (Pike et  al., 1995; 
Parsey et  al., 2002; Jovanovic et  al., 2008), and the density of 
5-HT1A receptors in this region is negatively correlated with lev-
els of 5-HIAA in the raphe nuclei in humans (Benwell et al. 1990). 
Therefore, smoking-induced changes in serotonin may alter the 
functioning of the raphe nuclei and hippocampal complex.
Given the role of serotonergic dysfunction in affective dis-
orders (Cannon et al., 2007; Coppen, 1967; Drevets et al., 2007), 
affective symptoms linked to tobacco withdrawal may be 
related to serotonin function. Brief abstinence from smoking 
increases negative affect, anxiety, and psychological withdrawal 
(Shiffman and Jarvik, 1976), and rapid abstinence-induced 
increases in negative affect and anxiety predict relapse during 
a quit attempt (Shiffman and Waters, 2004). Nicotine injection 
into the dorsal raphe nucleus produces anxiolytic effects in 
rodents (Cheeta et al., 2001); the serotonin system may there-
fore be a reasonable therapeutic target for symptoms of Tobacco 
Use Disorder, especially those related to affect.
Trials of selective serotonin reuptake inhibitors (SSRIs) as 
medications for smoking cessation have provided mixed results 
(Hughes et  al., 2007), in part because SSRIs indiscriminately 
affect serotonergic transmission, promoting serotonin bind-
ing at various receptor subtypes (Fletcher and Higgins, 2011). 
Medications with more selective actions may be more effective 
for smoking cessation. For example, lorcaserin, a 5-HT2C receptor 
agonist, decreased nicotine self-administration in rodents (Levin 
et al., 2011) and facilitated smoking cessation in humans during 
a 12-week randomized clinical trial (Shanahan et al., 2017).
It is important to consider young smokers in smoking cessa-
tion efforts, because those who stop smoking before the age of 25 
avoid most of the long-term negative consequences of smoking 
(Doll et al., 2004). Compared to older smokers, younger smokers 
smoke fewer cigarettes per day and are less nicotine-depend-
ent (Benowitz and Henningfield, 1994; Hammond et  al., 2008). 
Targeting young smokers may therefore result in higher sustained 
cessation rates than targeting older smokers (Messer et al., 2008).
No study has examined the relationship between serotonin-
ergic function and features of Tobacco Use Disorder in smok-
ers of any age. Although the raphe nuclei are relatively small 
and are not visible on a T1-weighted image acquired with MRI 
at 3 Tesla, one fMRI study localized the dorsal and median raphe 
nuclei by examining serotonin transporter (SERT) availabil-
ity using positron emission tomography (PET) (Beliveau et  al., 
2015). In that study, the dorsal and median raphe nuclei exhib-
ited resting-state functional connectivity with the hippocam-
pal complex, thalamus, striatum, insula, anterior and posterior 
cingulate cortices, and cerebellum; the median (but not the 
dorsal) raphe nucleus also exhibited connectivity with the pre-
cuneus and cuneus. Resting-state functional connectivity was 
positively associated with SERT availability in these regions 
(Beliveau et al., 2015).
We performed a seed-based analysis to assess the effects of 
smoking on resting-state functional connectivity of the dorsal 
and median raphe nuclei with the hippocampal complex as an 
indicator of serotonergic function. This investigation had 3 aims, 
addressed in 2 fMRI studies: (1) to compare connectivity of the 
raphe nuclei with the hippocampal complex in smokers vs non-
smokers; (2) to test the effects of acute smoking on connectivity 
of the raphe nuclei with the hippocampal complex; and (3) to 
examine the relationship of this connectivity with psychological 
withdrawal and craving for cigarettes. The hypotheses tested 
were that connectivity of the raphe nuclei with the hippocam-
pal complex would be: (1) weaker in smokers than in nonsmok-
ers; (2) negatively correlated with psychological withdrawal and 
craving; and (3) increased by smoking after overnight abstinence 
in association with decreases in psychological withdrawal and 
craving.
Methods
Participants and Procedures
Study 1: Smokers vs Nonsmokers
Study 1 employed a between-subjects design. Thirty-seven par-
ticipants (18 smokers, 19 nonsmokers, all 16–21  years of age) 
were recruited through online advertisements. At an intake ses-
sion, participants gave written informed consent after receiv-
ing a detailed explanation of the study (approved by the UCLA 
Institutional Review Board; IRB# 10-000259). Exclusion criteria 
were: positive urine test for illicit drugs (including marijuana), 
using an Instant-View immunoassay urine test (ALFA Scientific 
Designs, Inc.), self-report of marijuana use >8 times per month 
and alcohol use >5 days per month, any Axis I psychiatric dis-
order, including current drug abuse or dependence (other than 
nicotine dependence for those in the smoking group), history 
of neurological injury or disease or pregnancy, and contraindi-
cation for MRI scanning (e.g., metal material such as implants 
Significance Statement
This study extends previous observations that smokers have lower serotonin concentrations in the median raphe nucleus and 
hippocampal complex than nonsmokers to show smoking-related differences in serotonergic function and links to affective 
aspects of tobacco withdrawal in young smokers. Smokers exhibited weaker functional connectivity between these 2 serotonin-
rich regions than nonsmokers, and this weakness was associated with psychological withdrawal. Acute smoking increased 
connectivity, and this effect was associated with reductions in psychological withdrawal. Although selective serotonin reuptake 
inhibitors have produced mixed results in clinical trials for smoking cessation, the present findings motivate further research 
into the use of serotonergic pharmacotherapies for smoking cessation, indicating that they may be especially beneficial to smok-
ers who endorse high levels of psychological withdrawal.
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inside the body). Eighteen participants were classified as 
smokers based on endorsement of daily smoking for at least 
6 months and having CO concentrations of  >5 ppm in expired 
air (Smokerlyzer, Bedfont Scientific). All smokers completed the 
Fagerström Test for Nicotine Dependence (FTND; Fagerström, 
2012) at the intake session. Nineteen participants were classified 
as nonsmokers, because they endorsed having smoked fewer 
than 5 cigarettes in their lifetime and had CO levels of <5 ppm 
in expired air.
Testing was in the afternoon, and participants were 
instructed to avoid caffeine for 2 hours beforehand. Smokers 
were instructed to smoke as usual until 30 minutes before arriv-
ing at the testing site to minimize the effects of nicotine and 
abstinence on resting-state functional connectivity; smokers 
report only minimally (albeit significantly) greater withdrawal 
30 minutes compared to <1 minute after smoking a cigarette 
(Hendricks et al., 2006).
At the beginning of the testing session participants com-
pleted the Shiffman Jarvik Withdrawal Scale (SJWS) immedi-
ately before undergoing MRI scanning while in the resting state. 
These procedures were part of a larger testing battery (data 
to be reported elsewhere). The average duration of abstinence 
before completing the first testing battery (questionnaires) was 
41.56 minutes (SD = 36.26 minutes), and the average duration of 
abstinence prior to the resting state MRI scan was 49.87 minutes 
(SD = 41.22 minutes). For a timeline of Study 1 procedures, see 
supplementary Figure 1.
Study 2: Effects of Acute Smoking
Study 2 employed a within-subjects design. Twenty-four partici-
pants were recruited through online and print advertisements. At 
an initial intake session, participants gave written informed con-
sent after receiving a detailed explanation of the study (approved 
by the UCLA Institutional Review Board; IRB# 13-001240). 
Inclusion criteria were: 18 to 25 years of age and smoking at least 
5 cigarettes per day for at least 1 year. Exclusion criteria were: 
positive urine test for illicit drugs (including marijuana) [using an 
Instant-View immunoassay urine test (ALFA Scientific Designs, 
Inc.)]; self-report of marijuana use >8 times per month and 
alcohol use >10 days per month; DSM-IV psychiatric disorders 
including substance use disorder (other than nicotine depend-
ence); history of neurological injury or disease, pregnancy, or use 
of mentholated or electronic cigarettes; and contraindication 
for MRI scanning. Data from 3 participants with excessive head 
motion (>2.5 mm translation) were excluded, leaving data from 
21 participants for inclusion in the final analyses.
All participants were tested in the morning after overnight 
(~12 hours) abstinence from smoking, verified by measuring CO 
concentrations in expired air using a portable monitor (coVita), 
and again immediately after smoking one cigarette of their pre-
ferred brand. In each of the 2 testing sessions, one before and 
one after smoking the first cigarette of the day, participants were 
administered the SJWS and underwent fMRI scanning while in 
the resting state. These procedures were part of a larger testing 
battery described previously (Faulkner et al., 2017; Ghahremani 
et  al., 2018). The average time between the pre- and post-
smoking scans was 66.28 (SD = 8.49) minutes, and the average 
time between smoking and the post-smoking scan was 42.66 
(SD = 12.15) minutes. At the beginning of the intake session par-
ticipants also completed the FTND. For a timeline of Study 2 pro-
cedures, see supplementary Figure 2.
Smokers in Study 1 were, on average, significantly younger 
than those in Study 2 (F(1,56) = 41.257, P < .001). They also had 
slightly lower levels of nicotine dependence, but this difference 
was not statistically significant (Study 1 mean (SD): 2.56 (2.38); 
Study 2 mean (SD): 3.24 (1.76); F(1,37) = 1.056, P = .311).
Both Studies
The Psychological Withdrawal and Craving subscales of the 
SJWS (Shiffman and Jarvik, 1976) were used. The Psychological 
Withdrawal subscale comprises 8 items pertaining to the affect-
ive aspects of tobacco withdrawal, and the Craving subscale 
comprises 7 items. Because serotonin dysfunction is associated 
with affective disorders (e.g., Coppen, 1967; Drevets et al., 2007), 
the primary analyses pertained to data from the Psychological 
Withdrawal subscale; data from the Craving subscale were used 
in secondary analyses because of the importance of craving to 
relapse (e.g., Bagot et al., 2007).
fMRI Data Acquisition
Both Studies
Resting-state fMRI images were acquired over 5 minutes using a 
3-T Siemens AG Trio MRI system while participants viewed a black 
screen (152 T2*-weighted echoplanar images; repetition time = 2 
seconds; echo time = 30 milliseconds; slice thickness = 4 mm; flip 
angle = 90°; matrix: 64 × 64; field of view = 192 mm). For Study 1 a 
12-channel head-coil was used, and a 32-channel head coil was 
used for Study 2. In both studies a T2-weighted matched-band-
width anatomical scan was acquired for initial registration, and 
a T1-weighted magnetization-prepared rapid-acquisition gradi-
ent echo (MPRAGE) scan was acquired for further registration, 
including spatial normalization to standard space (Montreal 
Neurological Institute [MNI]).
fMRI Data Preprocessing
Image analysis was performed using the FMRIB Software Library 
(FSL) version 5.0.9 (www.fmrib.ox.ax.uk/fsl). The image time-
course of the resting state fMRI data was first realigned to com-
pensate for small head movements (Jenkinson et al, 2002). All 
non-brain matter was removed using FSL’s brain extraction tool. 
Time-series statistical analysis was carried out using FMRIB’s 
Improved Linear Model, with local autocorrelation correction 
(Woolrich et al, 2001) after highpass temporal filtering (Gaussian-
weighted LSF straight line fitting, with sigma = 50 seconds).
No participants were deemed to have had excessive head 
motion (>2.5 mm translation). For both studies, motion cleaning 
and noise reduction were performed using a 32-parameter lin-
ear regression model (Sattherthwaite et al., 2013) that included 6 
motion parameters (3 translational dimensions along x, y, and z 
axes and 3 rotational dimensions: “pitch”, “roll,” and “yaw”) com-
bined with the timeseries from the CSF and white matter to pro-
vide 8 parameters. The temporal derivatives of these parameters 
and the quadratic of all parameters resulted in 32 parameters. 
In addition, framewise displacement (FD) was determined with 
root-mean-squared matrix calculation (using FSL’s ‘fsl_motion_
outliers’ tool) to obtain the average rotation and translation par-
ameter differences across images. Time points that exceeded 
acceptable FD thresholds were included as “spike” regressors 
in the model (Power et al., 2012; 2013). A fixed threshold for all 
subjects was determined by calculating the SD of FD across all 
data and computing the following equation: 0.25  mm + 2  * SD 
(Sattherthwaite et  al., 2013). The time series of the resultant 
residuals from the regression model was then scaled and nor-
malized at each voxel: [(residuals - mean)/SD] + 100.
A seed-based approach was used with dorsal and median 
raphe nuclei masks created and provided by the authors of 
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Beliveau et al (2015). Specifically, these masks were defined at the 
single-subject level by examining [11C]DASB binding (to meas-
ure SERT availability) using PET. The masks were transformed 
into standard (MNI) space by first registering each subject’s PET 
image to their structural MR image (both in native space) using 
Freesurfer’s bbregister (https://surfer.nmr.mgh.harvard.edu/
fswiki/bbregister), then by registering the native space MR image 
to standard space (MNI) using FLIRT and FNIRT in FSL, and then 
by applying the resulting transformation matrices using a “near-
est neighbor” interpolation to bring the 2 raphe nuclei seeds into 
MNI space. These masks can be seen in (supplementary Figure 3). 
For a full description of how these masks were defined in subject-
space, see Beliveau et al (2015). The center-of-mass locations (in 
MNI space) were x = 0, y = -28, z = -12 for the dorsal raphe nucleus, 
and x = 0, y = -34, z = -20 for the median raphe nucleus. The dorsal 
raphe seed location extended from x = 4 to -6, y = -32 to -26, and 
z = -18 to -10. The median raphe seed location extended from x = 2 
to -6, y = -36 to -30, and z = -26 to -18.
Contrast images were registered through a 3-step proced-
ure; EPI images were first registered to the matched-bandwidth 
high-resolution structural image, then to the MPRAGE structural 
image, and finally into standard (MNI) space, using 12-parameter 
affine transformations (Jenkinson and Smith, 2001). Registration 
from MPRAGE structural images to standard space was further 
refined using FNIRT nonlinear registration (Andersson et  al, 
2007a). Images were smoothed using a 5-mm full-width at half-
maximum Gaussian kernel. Smoothing was performed after 
extraction of the timeseries data within the dorsal and median 
raphe nuclei to avoid the inclusion of signal from surrounding 
regions in higher-level analyses
fMRI Data Analysis
All group-level analyses (1 per raphe nucleus seed) were per-
formed using the general linear model (GLM) framework pro-
vided in FSL’s FLAME1 with outlier deweighting. To assess the 
effect of smoking status on connectivity of the raphe nuclei 
with the hippocampal complex (Study 1), 2 separate GLMs (1 
per raphe nucleus seed) were constructed, with 2 explanatory 
variables each (1 per group; smoker and nonsmoker). Group dif-
ferences were assessed by contrasting the parameter estimates 
for these 2 explanatory variables. To assess the acute effect of 
smoking on connectivity (Study 2), pre- vs post-smoking images 
were created using a fixed effects model in FSL’s FEAT, with each 
pre- and post-smoking image modelled with a 1 and -1, respect-
ively. The resulting contrast image for each participant was then 
submitted to a group-level analysis that contained one explana-
tory variable, denoting the group mean.
Because the hypotheses tested concerned connectivity of 
the raphe nuclei with the hippocampal complex, all group-level 
analyses were constrained by a hippocampal complex mask 
that contained the hippocampus, parahippocampal gyrus, and 
entorhinal cortex as defined by the Harvard-Oxford Atlas dis-
tributed within FSL. These analyses were followed by explora-
tory, whole-brain analyses to determine selectivity of the effects 
(see supplementary Materials).
All group-level statistical maps were cluster-corrected for 
multiple comparisons (voxel height threshold: Z > 3.1; cluster 
significance, P < .05). To examine the relationships of psycho-
logical withdrawal and craving with group differences in con-
nectivity (Study 1), as well as with the acute effects of smoking 
on connectivity (Study 2), connectivity values (z scores) were 
extracted from significant clusters and entered into the SPSS 
(SPSS Inc.) for correlation with behavioral measures.
Association of Connectivity with Behavioral 
Measures
Study 1
To test for associations of connectivity with psychological with-
drawal and craving in smokers, values of mean connectivity (z 
scores) from significant clusters were extracted and entered as 
one factor, along with sex, into 2 separate full-factorial ANOVAs, 
in which scores on the Psychological Withdrawal or Craving sub-
scales were the dependent variables. Sex was included as a separ-
ate factor because it influences tobacco withdrawal symptoms (e.g., 
Faulkner et al., 2018; Perkins et al., 1999; Xu et al., 2008). All analyses 
were performed in SPSS. Bonferroni corrections for all higher-level 
tests involving the 2 raphe nuclei were applied. However, given the 
role of serotonergic function in affective disorders, the hypotheses 
primarily tested relationships between raphe nuclei connectivity 
and psychological withdrawal; relationships between connectivity 
and craving were secondarily considered. As such, Bonferroni cor-
rections for the number of measures were not performed.
Study 2
To test for associations of psychological withdrawal and craving 
with connectivity of the raphe nuclei with the hippocampal com-
plex during abstinence, 2 separate group level analyses (one per 
self-report measure) were performed using FSL’s FLAME1 mod-
eling with outlier deweighting; these models contained either 
psychological withdrawal or craving scores as one EV. These 
statistical maps were cluster-corrected for multiple comparisons 
(voxel height threshold: Z > 3.09; cluster significance, P < .05).
To test for associations between the smoking-induced 
change in connectivity and the change in both psychological 
withdrawal and craving, 2 separate full-factorial ANOVAs were 
employed with scores on the psychological withdrawal or crav-
ing subscales as dependent variables and values of mean pre-
post smoking connectivity (z scores) from significant clusters 
entered as one factor, along with sex. Bonferroni corrections for 
the 2 raphe seeds were applied.
Results
Study 1
Self-Reports
Of the 37 participants who completed testing, 27 were male and 
10 were female (mean age 19.52 ± 2.20 years). A full description 
of participant characteristics for study 1 can be seen in Table 1. 
A  full-factorial ANOVA, constructed to examine the effects of 
smoking status, sex, and the interaction between the 2 on age of 
participants, showed no difference between smokers and non-
smokers in terms of age (smokers: 19.11 ± 4.60 years; nonsmok-
ers: 19.89 ± 1.20 years; F(1,33) = 0.381, P = .541). There was also no 
main effect of sex on age (males: 19.82 ± 0.96  years; females: 
1.940 ± 1.27 years; F(1,33) = 2.297, P = .179), and no smoking-status-
by-sex interaction (F = (1,33) = 0.700, p = .409). Psychological with-
drawal and craving were not significantly correlated (r = 0.293, 
P = .239).
Two of the participants were statistical outliers with respect 
to duration of smoking abstinence prior to testing (155 minutes 
and 142 minutes; group mean = 41.56 minutes, SD = 36.26) but 
not for psychological withdrawal (2.63 and 2.55, respectively; 
group mean = 2.48, SD = 0.61) or craving (4.40 and 1.00, respect-
ively; group mean = 2.12, SD = 1.23). The time since last cigarette 
was not correlated with psychological withdrawal (r = 0.221, 
P = .278) or craving (r = -0.092, P = .716).
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The full-factorial ANOVA revealed that there was no main 
effect of sex on either psychological withdrawal (F(1,16) = 0.022, 
P = .884), craving (F(1,16) = 0.415, P = .528), or FTND (F(1,16) = 0.573, 
P = .460).
Resting-State Connectivity
The mean number of images regressed out was 7.56 (SD = 5.44, 
range 0–21) for the smokers and 6.63 (SD = 5.44, range 0–19) for the 
nonsmokers. There was no significant difference between the 
number of images regressed out for each group (F(1,35) = 0.269, 
P = .607).
The voxel-wise GLM analysis revealed that, compared to 
nonsmokers, smokers displayed lower functional connectivity 
of the median raphe nucleus with the right hippocampal com-
plex (Figure  1). There was no group difference in connectivity 
involving the dorsal raphe nucleus and no significant results 
observed for the “smokers > nonsmokers” contrast.
The full-factorial ANOVA showed that, in smokers, connect-
ivity of the median raphe nucleus with the cluster of voxels 
within the hippocampal complex shown in Figure 1 was signifi-
cantly negatively correlated with psychological withdrawal; this 
relationship survived Bonferroni correction for the 2 raphe seeds 
(F(1,14) = 6.618, P = .022; Bonferroni-corrected P = .043) (Figure 2a). 
There was no effect of sex on this relationship (no sex-by-con-
nectivity interaction: F(1,14) = 0.578, P = .460). There was no sig-
nificant correlation of connectivity between the median raphe 
nucleus and hippocampal complex with craving (F(1,14) = 0.014, 
P = .907) (Figure 2b) and no effect of sex on this relationship (sex-
by-connectivity interaction: F(1,14) = 2.160, P = .164)
Study 2
Pre-smoking
Self-Reports—Of the 21 participants who completed testing, 
11 were male and 10 were female (mean age 22.28 ± 2.19 years). 
A full description of participant characteristics for study 2 can be 
seen in Table 1. There was no main effect of sex on age (males: 
23.08 ± 1.87 years; females: 22.09 ± 2.19 years; F(1,19) = 1.239, P = .280).
The mean psychological withdrawal was 3.32 (SD = 1.28), and 
the mean craving was 5.09 (SD = 1.70). The full-factorial ANOVA 
revealed that there was no main effect of sex on psychological 
withdrawal (F(1,18) = 2.425, P = .136), craving (F(1,18) = 1.140, 
P = .200), or FTND (F(1,18) = 0.256, P = .619).
During abstinence, one participant was an outlier with 
regard to craving (female; craving = 0); therefore, abstinence 
data from only the remaining 20 participants were analyzed (11 
males, 9 females; mean age 22.47 ± 2.23 years). Mean psychologi-
cal withdrawal was 3.46 (SD = 1.15), and mean craving was 5.49 
(SD = 1.27), with no differences between these 11 males and 9 
females [psychological withdrawal: F(1,17) = 1.422, P = .248; and 
craving: F(1,17) = 0.022, P = .884].
Resting-State Connectivity
Examination of the correlations between connectivity of the 
raphe nuclei and hippocampal complex with psychological 
withdrawal and craving values from the pre-smoking testing 
session revealed no significant clusters, both when including 
and excluding the outlying participant.
Changes from Pre- to Post-Smoking
Self-Reports
The full-factorial ANOVAs revealed that smoking decreased 
psychological withdrawal (F(1,36) = 6.151, P = .017; Bonferroni-
corrected P = .033) and craving (F(1,36) = 17.380, P < .001; Bonferroni-
corrected P < .001). There was a significant main effect of sex on 
smoking-induced reductions in psychological withdrawal (36% 
reduction in women, 17% reduction in men; F(1,17) = 12.233, 
P = .003; Bonferroni-corrected P = .006), and in craving (28% reduc-
tion in women, 22% reduction in men; F(1,17) = 8.074, P = .011; 
Bonferroni-corrected P = .021) (supplementary Figure  8). None 
of the change scores were statistical outliers; therefore, exami-
nations of the relationship between dorsal and median raphe 
nuclei connectivity and both psychological withdrawal and crav-
ing included data from all 21 participants.
Resting-State Connectivity
The voxel-wise GLM showed that smoking increased connectiv-
ity of the median raphe nucleus with a cluster of voxels in the 
right hippocampal complex (Figure 3). There was no significant 
effect of smoking on connectivity of the dorsal raphe nucleus 
with the hippocampal complex.
The full-factorial ANOVA determined that the smoking-
induced increase in connectivity of the median raphe nucleus 
with the hippocampal complex cluster shown in Figure 3a was 
negatively correlated with the reduction in psychological with-
drawal (F(1,18) = 6.409, P = .020) but not with the reduction in 
craving (F(1,18) = 0.828, P = .375) (Figure  4). There was no effect 
of sex on either relationship (i.e., no sex-by-connectivity inter-
action on psychological withdrawal: F(1,18) = 2.288, P = .148, or 
craving: F(1,18) = 0.035, P = .853).
Discussion
Compared to nonsmokers, smokers displayed weaker resting-
state functional connectivity between the median raphe nuclei 
Figure 1. Group difference in connectivity of the median raphe nucleus. Data shown are from Study 1. (A) Cluster denotes the region in which connectivity with the 
median raphe nucleus is weaker in smokers than in nonsmokers. Result is cluster-corrected for multiple comparisons (voxel height threshold: Z > 3.09; cluster signifi-
cance: P < .05). (B) Graph depicts mean Z values from the cluster shown in (A) for the smoking and nonsmoking group and are for illustrative purposes only.
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and hippocampal complex. Connectivity of the median raphe 
nuclei was related to psychological withdrawal, and smoking-
induced increases in this potential marker of serotonin function 
were related to the acute relief of the psychological, affec-
tive aspects of tobacco withdrawal. These results suggest that 
increasing connectivity of the median raphe nuclei with the hip-
pocampal complex may reduce psychological withdrawal and 
possibly facilitate smoking cessation.
Smoking-induced increases in connectivity between the 
median raphe nucleus and hippocampal formation may reflect 
nicotine-induced serotonin release within these regions, as 
observed in rodents (Kenny et  al., 2000; Cheeta et  al., 2001). 
Weaker connectivity of the median raphe nucleus with the hip-
pocampal complex in smokers relative to nonsmokers may 
reflect both greater 5-HT1A receptor binding and lower serotonin 
concentrations, which have been observed in these regions in 
smokers (Benwell et al., 1990). It has been argued that repetitive 
nicotine–induced serotonin release in the raphe nuclei and hip-
pocampal complex produces upregulation of 5-HT1A receptors in 
these regions, thereby inhibiting serotonergic neuronal firing and 
decreasing serotonin levels (Benwell et al., 1990). This hypothesis is 
supported by a negative correlation between serotonin concentra-
tions in the median raphe nucleus and 5-HT1A receptor availability 
in the hippocampal complex (Benwell et al., 1990). Future research 
could examine whether pharmacotherapies that desensitize or 
downregulate 5-HT1A receptors in the median raphe nucleus and 
hippocampal complex can increase both serotonin levels and con-
nectivity between these 2 regions to influence smoking cessation.
Figure 2. Relationship of connectivity of the median raphe nucleus and hippocampal complex with psychological withdrawal (A) and craving (B) in smokers. Data 
shown are from Study 1. Plots depict Z values from each participant reflecting connectivity strength.
Figure 3. Effect of acute smoking on connectivity of the median raphe nucleus with the hippocampal complex in smokers after overnight abstinence. Data shown are 
from Study 2. (A) Cluster denotes the region in which connectivity with the median raphe nucleus increased due to smoking. Result is cluster-corrected for multiple 
comparisons (voxel height threshold: Z > 3.09; cluster significance: P < .05). (B) Graph depicts mean Z values from the cluster shown in (A) for the pre- and post-smoking 
session and are for illustrative purposes only.
Figure 4. Relationship of the smoking-induced increase in connectivity of the median raphe nucleus with the hippocampal complex to the reduction in psychological 
withdrawal (A) and craving (B). Data shown are from Study 2. Plots depict Z values from each participant extracted from the cluster in the hippocampal complex 
observed in Figure 3A.
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The correlation between connectivity of the median raphe 
nucleus with the hippocampal complex and psychological with-
drawal was predicted on the basis of the proposed role of seroto-
nin in affective disorders (e.g., Coppen, 1967; Drevets et al., 2007). 
While this study did not examine serotonin function per se, the 
results encourage future research on the potential involvement 
of serotonergic dysfunction in other aspects of tobacco with-
drawal. For example, high impulsivity predicts relapse during a 
cessation attempt (Krishnan-Sarin et al., 2007), is increased by 
serotonergic hypofunction (Faulkner and Deakin, 2014), and is 
related to hippocampal 5-HT1A availability in healthy controls 
(Faulkner et al., 2014).
SSRIs, which increase central serotonin levels, have only mild 
efficacy in aiding smoking cessation (e.g., Niaura et al., 2002). As 
mentioned, this may be due to the nonselective effect of these 
drugs on serotonergic transmission. In contrast, lorcaserin, a 
5-HT2C receptor agonist, facilitates smoking cessation (Shanahan 
et  al., 2016). This effect of lorcaserin and its ability to reduce 
nicotine self-administration in rats (Higgins, et  al., 2012; Levin 
et al., 2011) may reflect links between the 5-HT2C receptors and 
the dopaminergic reward system. In rodents, activation of 5-HT2C 
receptors by RO 60–0175 blocks the stimulatory action of nicotine 
on midbrain dopamine neuron firing (Pierucci et al., 2004).
Other serotonergic medications may help smokers to quit. 
The low efficacy of conventional SSRIs for smoking cessation 
may reflect their initial action to decrease serotonin levels 
through serotonin activity at inhibitory 5-HT1A autoreceptors in 
the raphe nuclei (e.g., Selvaraj et al., 2012). Because of the high 
concentration of 5-HT1A receptors in the hippocampal complex 
(Pike et al., 1995; Parsey et al., 2002; Jovanovic et al., 2008), block-
ing 5-HT1A receptors in this region may increase the efficacy of 
serotonergic pharmacotherapies for smoking cessation (e.g., 
Fletcher et al., 2008). Indeed, fluoxetine has a greater effect to 
decrease nicotine withdrawal in rats when co-administered 
with the 5-HT1A receptor antagonist, p-MPPI than when admin-
istered alone (Harrison et al., 2001). Future studies could exam-
ine whether blocking 5-HT1A receptors in the raphe nuclei or 
hippocampus could alter raphe function and augment seroton-
ergic functioning sufficiently to facilitate smoking cessation.
Although nicotine promotes serotonin release in the raphe 
nucleus, which has a high density of α4β2 nicotinic acetylcho-
line receptors localized to serotonergic neurons (Cheeta et al., 
2001), other neurochemical mechanisms may also explain the 
current results. One possible mechanism is smoking-induced 
dopamine release, considering the moderate number of dopa-
mine neurons in the dorsal raphe nucleus (Geffard et al., 1987; 
Kalén et  al., 1988). However, interactions at dopamine D2-like 
receptors on serotonin neurons in the raphe nuclei increase 
extracellular serotonin concentrations in the raphe nuclei (Ferré 
and Artigas, 1993; Aman et al., 2007), indicating that serotoner-
gic mechanisms, at least in part, explain the results.
This study has limitations. Because fMRI does not allow dir-
ect examination of the serotonin system, the role of serotonin 
in the effects observed is only inferred. To help clarify the role 
of serotonin on the relationship between tobacco withdrawal 
and connectivity of the median raphe nuclei, future studies 
could examine effects of serotonergic medications on with-
drawal symptoms and associated changes in brain function. 
As the participants were exclusively young smokers with 
short smoking histories and mild-to-moderate levels of nico-
tine dependence, as expected from smokers within this age 
range (e.g., Li et al., 2015; Bi et al., 2017; Faulkner et al., 2017), 
the results may not be generalizable to the wider population 
of smokers. Also, the small sample size and uneven gender 
distribution made it difficult to examine the influence of sex. 
Further, because of differences between the dorsal and median 
raphe nuclei in resting-state functional connectivity (Beliveau 
et al., 2015), connectivity of these 2 regions was tested separ-
ately, increasing the chance of a type-1 error occurring due to 
the number of GLMs performed. However, Bonferroni correc-
tions for the number of seeds were performed on all higher-
level analyses. Finally, the short fMRI scan duration (5 minutes) 
is a potential limitation. However, when resting-state connect-
ivity analyses were performed on data collected from 2 to 11 
minutes, the average correlation strengths of time-courses 
in data collected during 5 minutes were comparable with the 
correlation strengths in data collected over 11 minutes (van 
Dijk et al., 2010).
Table 1. Participant Characteristics
Study 1 Study 2
(Smokers) (Nonsmokers) (Smokers)
n 18 19 21
Sex (M/F) 14/4 13/6 11/10
Age (y)a 19.11 (4.60) 19.89 (1.20) 22.28 (2.19)
Education (y)a 10.78 (1.38) 11.23 (1.45) 13.79 (1.70)
Ethnicity (no. of participants)
 White Caucasian 13 12 19
 African American 0 1 10
 Asian American 2 2 8
 Hispanic 2 2 6
 Other 1 2 3
Cigarette smokinga
 Age of first use (y) 16.50 (2.17) - 16.37 (2.20)
 Cigarettes per day 9.31 (6.78) - 11.59 (6.17)
 Nicotine dependencea 2.57 (2.38) - 3.55 (2.03)
Substance use a
 Marijuana (days used in past 30) 0.73 (0.48) 0.52 (0.54) 1.43 (2.10)
 Alcohol (drinks/week) 1.12 (2.31) 0.98 (1.73) 2.92 (3.89)
aDenotes mean (SD).
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